GSK and Merck cut vaccine prices
June 6, 2011Sales and Marketing Bill and Melinda Gates Foundation, GSK, Merck & Co, developing world, vaccines
GlaxoSmithKline and Merck & Co have pledged to offer their rotavirus vaccines at discounted prices to developing countries. GSK is …
UK pharma opposes off-label rule change
June 6, 2011Sales and Marketing off label
Prescribing a drug off-label when a licenced alternative exists increases patient safety risks and threatens the development of new medicines, …
Novartis eye drug wins wider European licence
June 6, 2011Sales and Marketing Lucentis, Novartis
Novartis’ Lucentis has been approved in Europe to treat people suffering from vision loss due to macular oedema secondary to …
Service Insight: Video killed the radio star …
June 6, 2011Medical Communications Service Insight, digital marketing, social media
SERVICE INSIGHTWhile everyone is going digital, are we forgetting the power of the spoken word? Some days it feels as …
NHS reform: after the pause, the rewind?
June 3, 2011Andrew Lansley, NHS reform
The government’s six-week ‘pause’ in the passage of the controversial Health and Social Care Bill has now come to an …
Health Bill ignores research, says charity
June 3, 2011Cancer Research UK, NHS, trials
The Health and Social Care Bill has ignored the opportunity to place clinical research at the heart of the NHS, …
BMS and Roche to team up in melanoma
June 3, 2011Sales and Marketing BMS, Roche, melanoma, oncology
Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …
Tarceva impresses again as it seeks to extend its EU licence
June 3, 2011NSCLC, Roche, Tarceva
Roche and its partner OSI Pharmaceuticals have released another series of positive results for its lung cancer drug Tarceva as …
UNICEF highlights price differences for vaccines
June 2, 2011Sales and Marketing Unicef, developing world, vaccines
A large disparity in the cost of vaccines has been revealed by UNICEF. The United Nations Children’s Fund charity has …
Functional excipients driving US market growth
June 2, 2011Manufacturing and Production API, excipients, functional excipients
Drugmakers are increasingly using more sophisticated excipients and blends in order to defend against generic competition, according to new market …
AstraZeneca to stop paying for international conference trips
June 2, 2011Medical Communications, Sales and Marketing AstraZeneca, congresses, ethics
AstraZeneca will no longer pay for doctors to attend international conferences. The move is the latest development in the industry’s …
Who is the customer in the new NHS?
June 2, 2011ABPI, Ben Adams, GP consortia, NHS reform, PCTs
As the structure of the NHS is ripped down and rebuilt, the pharma industry is finding itself working in a …
FDA goes public with enforcement actions
June 2, 2011Manufacturing and Production FDA, transparency
The FDA is to publish more details about inspections and court actions on its website as part of a drive …
Pfizer files new kidney cancer drug
June 2, 2011Sales and Marketing Nexavar, Pfizer, rcc
Pfizer has filed its kidney cancer drug axitinib in the EU after impressive head-head- trials with Bayer’s Nexavar. Pfizer is …
Reforms will weaken health service accountability
June 1, 2011Sales and Marketing NHS reform, king's fund
The government has received yet more unwelcome news on health policy with a leading think tank warning its reforms will …
SCM wins contract to make high-potency cancer drug
May 31, 2011Manufacturing and Production SCM Pharma, Speciality European Pharma
UK contract manufacturing organisation SCM Pharma has been awarded a contract to make commercial supplies of a cancer drug due …
Pharma manufacturing news in brief
May 31, 2011Manufacturing and Production Aurobindo Pharma, Gallus, Lonza, ProMetic, Unigene
This week’s round-up of pharmaceutical manufacturing news includes new contracts for ProMetic and Unigene, plus facility updates from Aurobindo, Gallus …
Bayer wields the axe at Emeryville plant
May 31, 2011Manufacturing and Production Bayer, Emeryville, MS
Bayer Healthcare says it will cut 540 jobs at a production facility in Emeryville, California, next year after shifting production …
Quality by Design – the new manufacturing paradigm
May 31, 2011Manufacturing and Production Quality by Design, pharma manufacturing
Pharmaceutical manufacturing currently operates using processes that are widely seen as inefficient, inflexible and outdated. In the current system of …
Pfizer simplifies contract research with Parexel and Icon
May 27, 2011Research and Development ICON, Parexel, Pfizer, cros
Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
